Citigroup
MAIA icon

Citigroup’s MAIA Biotechnology MAIA Stock Holding History

Citigroup’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216 Buy
150
+128
+582% +$170 ﹤0.01% 5493
2026
Q1 		$31 Sell
22
-1,716
-99% -$3.16K ﹤0.01% 5676
2025
Q4 		$2.66K Buy
1,738
+1,208
+228% +$1.58K ﹤0.01% 5406
2025
Q3 		$816 Buy
+530
New +$866 ﹤0.01% 5657

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup's MAIA Position: Q2 2026 in Review

Citigroup increased its MAIA Biotechnology (MAIA) stake by 582% in Q2 2026, buying an estimated $170 and bringing the position to 150 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #5493.

Citigroup first reported a position in MAIA in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.66K in Q4 2025. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Citigroup held 150 shares of MAIA Biotechnology worth $216 as of Q2 2026.
  • Citigroup bought 128 MAIA Biotechnology shares in Q2 2026, an estimated $170.
  • MAIA Biotechnology made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5493 holding.
  • Citigroup first reported a position in MAIA Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • Citigroup's MAIA Biotechnology position peaked at $2.66K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.